AI assistant
Sending…
Ascelia Pharma — Major Shareholding Notification 2024
Jul 25, 2024
3132_iss_2024-07-25_1d58cb45-304e-4a09-af1e-6dc8ade5b968.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Ascelia Pharma AB
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument | |
|---|---|
| Instrument | Aktier |
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 24/07/2024 |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,527,541 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 1,527,541 |
| Percentage | |
| Directly held shares | 4.38053 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.51013 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.51013 % | 1,527,541 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 4.51013 % | 1,527,541 |
Group total holdings
Voting rights 1,527,541
Percentage of voting rights 4.51013
Notes (other relevant informations according to law)
Aktierna innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.
Published
25/07/2024 09:46
Contact
Name Marie Andersson
Email [email protected]
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Ascelia Pharma
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
AGM Information
2026
May 4
AGM Information
2026
May 4
Share Issue/Capital Change
2026
Apr 30
Share Issue/Capital Change
2026
Apr 30
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 23
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Mar 30